Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The ovary: basic biology and clinical implications
JoAnne S. Richards, Stephanie A. Pangas
JoAnne S. Richards, Stephanie A. Pangas
Published April 1, 2010
Citation Information: J Clin Invest. 2010;120(4):963-972. https://doi.org/10.1172/JCI41350.
View: Text | PDF
Review Series

The ovary: basic biology and clinical implications

  • Text
  • PDF
Abstract

The classical view of ovarian follicle development is that it is regulated by the hypothalamic-pituitary-ovarian axis, in which gonadotropin-releasing hormone (GnRH) controls the release of the gonadotropic hormones follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and that ovarian steroids exert both negative and positive regulatory effects on GnRH secretion. More recent studies in mice and humans indicate that many other intra-ovarian signaling cascades affect follicular development and gonadotropin action in a stage- and context-specific manner. As we discuss here, mutant mouse models and clinical evidence indicate that some of the most powerful intra-ovarian regulators of follicular development include the TGF-β/SMAD, WNT/FZD/β-catenin, and RAS/ERK1/2 signaling pathways and the FOXO/FOXL2 transcription factors.

Authors

JoAnne S. Richards, Stephanie A. Pangas

×

Figure 3

LH-mediated pathways to ovulation and luteinization.

Options: View larger image (or click on image) Download as PowerPoint
LH-mediated pathways to ovulation and luteinization.
LH induces ovulatio...
LH induces ovulation, COC expansion, oocyte maturation, and luteinization in preovulatory follicles. These events are mediated by LH activation of the PKA pathway and NRIP1, which induce the expression of the EGF-like factors (AREG, EREG). AREG and/or EREG in turn activate the EGFR signaling cascade, including RAS and ERK1/2. This hypothesis is based on the observations that when Erk1 and Erk2 are disrupted in granulosa cells, global changes occur in gene expression patterns that control ovulation, COC expansion, resumption of meiosis, and luteinization. Moreover, activation of ERK1/2 is essential to turn off the FSH-regulated gene expression program that controls genes essential for preovulatory follicle growth and differentiation. C/EBPα and C/EBPβ, NR5A2 (also known as LRH1), and possibly PGR appear to be among the key transcription factors that are activated by ERK1/2 phosphorylation and affect ovulation and luteinization. Other transcription factors that are targets of ERK1/2 include members of the AP1 family and EGR1/3, whose specific functions in ovulation and luteinization remain to be defined. Additionally, oocyte-derived factors such as GDF9 and BMP15 affect cumulus cell and granulosa cell functions in a gradient-dependent manner. The functions of specific genes are discussed in the text. TK, tyrosine kinase.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts